![semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 2·4 mg](https://figures.semanticscholar.org/7fe85daed4f884830ea71a1fe88205a43e1c1a7f/4-Table1-1.png)
semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 2·4 mg
USD25.16
USD47.16
Pay in 4 interest-free payments of $6.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
![semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 24 mg](https://www.thelancet.com/cms/10.1016/S2468-1253(23)00068-7/asset/fd53a887-7fc5-47e3-8cb1-2f290875bdb9/main.assets/gr3_lrg.jpg)
![semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 24 mg](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3844108186970877862)
![semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 24 mg](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4169706f-104a-43d4-a1e6-ced8f1d754cf/dom14863-fig-0002-m.jpg)
![semaglutide phase 2 PDF] Efficacy and safety of compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, trial semaglutide and nafld 24 mg](https://www.researchgate.net/publication/372242176/figure/fig1/AS:11431281473860336@1748548467029/Semaglutide-exposure-levels-in-STEP-1-STEP-2-and-the-phase-2-trial-Data-are-individual.png)
